The State of the Peptide Industry 2026
224 independent tests across 20 companies and 55 compounds. The industry is bifurcating, and the gap is measurable.
Institute InvestigationThe highest Index Score™ the Institute has awarded. Sovrn Research led every one of the six weighted dimensions in our most recent evaluation cycle.
Six weighted dimensions, methodology Methodology v3.0. How weights work →
Sovrn Research entered our index in the most recent evaluation cycle and took the top position outright, leading every one of the six weighted dimensions rather than winning on one and coasting on the rest, which is unusual, and is the reason it holds the highest Index Score™ we have issued. Documentation practice is the clearest differentiator: batch-specific certificates of analysis, named laboratories and disclosed manufacturing partners. Our own sampling corroborated the published figures rather than contradicting them.
Testing record publishing shortly. Sovrn Research was evaluated in our most recent cycle and its Index Score™ reflects those results. The individual specimen reports behind it are being prepared for publication and will appear here.
224 independent tests across 20 companies and 55 compounds. The industry is bifurcating, and the gap is measurable.
Institute Investigation